_____________________________________________________________________________________________________________ Hikma
strengthens product safety and reliability while reducing regulatory risks.”
As a top three supplier of generic injectables in the US, we develop and manufacture simple and complex injectables products that actively help tackle critical medical requirements in hospitals.
A prime example is the recent launch of Tyzavan ®, an FDA-approved, ready-to-infuse glycopeptide antibacterial agent designed to treat serious infections.“ Tyzavan ® is a vancomycin premix with room temperature stability,” Natheer explains.“ Offered in prefilled bags, it enables patients to be treated more efficiently with a reduced risk of compounding errors, demonstrating how we leverage our capabilities to serve the evolving needs of healthcare professionals and their patients.
Pharmaceutical
Labels for Injectables, Liquids, Semisolids and Solids.
Booklet Labels Double layer label Hanger label Tamper Evident Label
Trusted Partner for Pharmaceutical Product Labels.
50 + YEARS’ EXPERIENCE
STATE OF THE ART TECHNOLOGIES, PRINTING AND INSPECTION
COMPLEX LABELS AND BOOKLETS GMP PRACTICES
“ Another key example came during the Covid pandemic when we prioritized criticalcare medicines, such as respiratory drugs, analgesics, and anti-infectives. We operated at maximum capacity to meet the surging demand, and, during that time, we supplied 11 of the 13 most used intensive care unit injectables in the US.
“ Importantly, we work closely with regulatory authorities to ensure essential medicines remain consistently available. By proactively monitoring potential supply disruptions and collaborating with partners, we can anticipate shortages, scale production when needed, and maintain continuity of care in a volatile market.”
Leveraging advanced technologies strengthens efficiency, precision, and compliance within the company’ s production sites. By embedding automation, digital monitoring, and data-driven decisionmanufacturing-today. com 43